Gellner's been hooked on the squishy white bread her whole life. Which is why when she noticed it missing from the shelves at her local grocer about a year ago, she was disappointed to say the least.
"I heard it was coming back months ago and I've been looking for it ever since," Gellner said.
At least at a handful of Delaware supermarkets, the search for the Wonder bread diehards is over.
It's back.
"I'm very glad," said Gellner, with a fresh loaf sitting in the top basket of her grocery cart. "I missed it. I always got my kids Wonder bread. I was so happy I had to text my daughter in Florida and tell her, 'Guess what? I'm eating a peanut butter and jelly sandwich on Wonder bread.'"
Top 10 Long Term Companies To Invest In Right Now: Oracle Corporation(ORCL)
Oracle Corporation, an enterprise software company, develops, manufactures, markets, distributes, and services database and middleware software, applications software, and hardware systems worldwide. It licenses of database and middleware software, including database management software, application server software, service-oriented architecture and business process management software, data integration software, business intelligence software, identity and access management software, content management software, portals and user interaction software, development tools, and Java; and applications software comprising enterprise resource planning, customer relationship management, enterprise performance management, supply chain management, business intelligence applications, enterprise portfolio project management, Web commerce, and industry-specific applications software. The company also offers customers with rights to unspecified software product upgrades and maintenance releases; Internet access to technical content; and Internet and telephone access to technical support personnel. In addition, its hardware systems products consist of computer server and hardware-related software, including the Oracle Solaris Operating System; and storage products, such as tape, disk and networking solutions for open systems and mainframe server environments. Its hardware systems support solutions include software updates for the software components. Further, the company offers consulting solutions in business and IT strategy alignment, enterprise architecture planning and design, initial product implementation and integration, and ongoing product enhancements and upgrades; cloud services, including Oracle Cloud Services and Advanced Customer Services; and education solutions comprising instructor-led, media-based, and Internet-based training in the use of its software and hardware products. The company was founded in 1977 and is headquartered in Redwood Ci ty, California.
Advisors' Opinion:- [By M. Joy, Hayes]
Last year, Oracle (NYSE: ORCL ) CEO Larry Ellison was awarded 7 million stock options, valued at $90.7 million, in the face of significant shareholder disapproval. Oracle's board defended the decision by pointing out that the $90.7 million valuation isn't necessarily an accurate measure of the compensation Ellison will receive.
- [By WALLSTCHEATSHEET]
Oracle has steadily increased revenue and earnings on an annual basis. The stock is trading at 16 times earnings, whereas the industry average is 26 times earnings. The stock is more resilient than most throughout the broader market, margins are high, there is a 0.70 yield, operating cash flow is strong at $13.72 billion, 80 percent of employees approve of CEO Larry Ellison, and analysts love the stock: 27 Buy, 15 Hold, 1 Sell.
- [By Chuck Carnevale]
Oracle Corp (ORCL) Historical Graph
��racle Corp, incorporated in 2005, is a provider of enterprise software and computer hardware products and services. The Company's software, hardware systems, and services businesses develops, manufactures, markets, hosts and supports database and middleware software, applications software, and hardware systems, with the latter consisting primarily of computer server and storage products.��/p>
Best Supermarket Stocks To Buy For 2014: Merrimack Pharmaceuticals Inc (MACK)
Merrimack Pharmaceuticals, Inc., incorporated in 1993, is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company�� product candidates include MM-398, MM-121, MM-111, MM-302 and MM-151. As of June 31, 2011, the Company owned approximately 74% interest of Silver Creek.
The Company�� Network biology is an interdisciplinary approach to drug discovery and development that enables the Company to build functional and predictive computational models of biological systems based on quantitative, kinetic, multiplexed biological data. The Company provides its scientists with insights into how the complex molecular interactions that occur within cell signaling pathways, or networks, regulate cell decisions and how dysfunction within these networks leads to disease. The Company applies network biology throughout the research and development process, including for target identification, lead compound design and optimization, diagnostic discovery, in vitro and in vivo predictive development and the design of clinical trial protocols.
MM-398
MM-398 is a stable nanotherapeutic encapsulation, or enclosed sphere carrying an active drug, of the marketed chemotherapy drug irinotecan. MM-398 achieved its primary efficacy endpoints in Phase 2 clinical trials in pancreatic and gastric cancer. In an open label, single arm Phase 2 clinical trial of MM-398 as a monotherapy in 40 metastatic pancreatic cancer patients who had previously failed treatment with gemcitabine, patients treated with MM-398 achieved median overall survival of 22.4 weeks. Additionally, 20% of the patients in this Phase 2 trial survived for more than one year, and the Company observed a disease control rate, meaning patients exhibited stable disease or partial or complete response to treatment, of 47.5% at six weeks.
The Company focuses on initiati! ng a Phase 3 clinical trial of MM-398 for the treatment of patients with metastatic pancreatic cancer who have previously failed treatment with gemcitabine. The trial is expected to enroll approximately 250 patients and is designed to compare the efficacy of MM-398 as a monotherapy against the combination of the chemotherapy drugs fluorouracil, or 5-FU, and leucovorin. There are multiple ongoing Phase 1 and Phase 2 clinical trials of MM-398. In July 2011, the United States Food and Drug Administration (FDA) granted MM-398 orphan drug designation for the treatment of pancreatic cancer.
MM-121
MM-121 is a fully human monoclonal antibody that targets ErbB3, a cell surface receptor, or protein attached to the cell membrane that mediates communication inside and outside the cell, that the Company�� network biology approach identified as a target in a range of cancers. A monoclonal antibody is a type of protein normally produced by cells of the immune system that binds to just one epitope, or chemical structure, on a protein or other structure. MM-121 is designed to inhibit cancer growth directly, restore sensitivity to drugs to which a tumor has become resistant and delay the development of resistance of a tumor to other agents. In collaboration with Sanofi, the Company focuses on testing MM-121 in combination with both chemotherapies and other targeted agents across a range of spectrum of solid tumors, including lung, breast and ovarian cancers. The Company partnered MM-121 with Sanofi after it initiated Phase 1 clinical development of the product candidate.
MM-111
MM-111 is a bispecific antibody designed to target cancer cells that are characterized by overexpression of the ErbB2 cell surface receptor, also referred to as HER2. A bispecific antibody is a type of antibody that is able to bind simultaneously to two distinct proteins or epitopes. The Company�� network biology approach identified that ligand-induced signaling through the complex of ErbB2 ! (HER2) an! d ErbB3 is a promoter of tumor growth and survival than previously appreciated.
MM-302
MM-302 is a nanotherapeutic encapsulation of doxorubicin with attached antibodies that are designed to target MM-302 to cells that over express the ErbB2 (HER2) receptor. The Company is conducting a Phase 1 clinical trial of MM-302 in patients with advanced ErbB2 (HER2) positive breast cancer.
MM-151
MM-151 is an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor (EGFR). EGFR is also known as ErbB1. An oligoclonal therapeutic is a mixture of two or more distinct monoclonal antibodies. The Company has designed MM-151 to block signal amplification that occurs within the ErbB cell signaling network. The Company has submitted an investigational new drug application (IND), to the FDA for MM-151 in July 2011.
Advisors' Opinion:- [By John Udovich]
One way or the other, Merrimack Pharmaceuticals Inc (NASDAQ: MACK), Covidien plc (NYSE: COV), NeoGenomics, Inc (NASDAQ: NEO) and�CollabRx Inc (NASDAQ: CLRX) are targeting Barrett's Esophagus�or�esophageal cancer�(the former often leads to the latter) ��a form of cancer that may not be on the top of your list of cancers but is nevertheless on the rise. Approximately 3 million Americans suffer from Barrett's Esophagus, �a condition that�develops as a result of chronic injury from gastroesophageal reflux disease (GERD) where the�normal esophageal lining is replaced with abnormal cells (known as Barrett�� tissue), putting patients at greater risk of developing cancer of the esophagus. And although less than 1% of these patients develop cancer each year, esophageal carcinoma is frequently not detected until later stages, at which point therapy options are limited, extremely invasive, and often ineffective.�This means that�early detection is important�along with�regular surveillance is recommended.�
- [By Roberto Pedone]
One under-$10 biopharmaceuticals player that's just starting to trigger a breakout trade is Merrimack Pharmaceuticals (MACK), which focuses on discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. This stock has been hit hard by the bears so far in 2013, with shares off by 38%.
If you take a look at the chart for Merrimack Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last two months, with shares plunging from its high of 7.09 to its recent low of $3.26 a share. During that move, shares of MACK have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of MACK have just formed a double bottom chart pattern at $3.26 to $3.32 a share and it's now starting to break out above some near-term overhead resistance at $3.64 a share. This move could be signaling a trend change for MACK as the stock starts to move higher off oversold conditions.
Traders should now look for long-biased trades in MACK if it manages to break out above some near-term overhead resistance at $3.64 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.87 million shares. If that breakout triggers soon, then MACK will set up to re-test or possibly take out its next major overhead resistance level at its 50-day moving average of $4.75 a share. Any high-volume move above that level and above more resistance at $5.06 will then give MACK a chance to tag its 200-day moving average at $5.71 a share.
Traders can look to buy MACK off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.32 or at $3.26 a share. One can also buy MACK off strength once it clears $3.64 a share with volume and then simply use a stop tha
Best Supermarket Stocks To Buy For 2014: Petroleo Brasileiro S.A.- Petrobras(PBR)
Petroleo Brasileiro S.A. primarily engages in oil and natural gas exploration and production, refining, trade, and transportation businesses. The company?s Exploration and Production segment involves in the exploration, production, development, and production of oil, liquefied natural gas (LNG), and natural gas in Brazil. This segment supplies its products to the refineries in Brazil, as well as sells surplus petroleum and byproducts in domestic and foreign markets. Its Supply segment engages in the refining, logistics, transportation, and trade of oil and oil products; export of ethanol; and extraction and processing of schist, as well as holds interests in companies of the petrochemical sector in Brazil. The Gas and Energy segment involves in the transportation and trade of natural gas produced in or imported into Brazil; transportation and trade of LNG; and generation and trade of electric power. In addition, the segment has interests in natural gas transportation and d istribution companies; and thermoelectric power stations in Brazil, as well engages in fertilizer business. The Distribution segment distributes oil products, ethanol, and compressed natural gas in Brazil. The International segment involves in the exploration and production of oil and gas, as well as in supplying, gas and energy, and distribution operations in the Americas, Africa, Europe, and Asia. Further, the company involves in biofuel production business. Petroleo Brasileiro was founded in 1953 and is based in Rio de Janeiro, Brazil.
Advisors' Opinion:- [By Aaron Levitt]
Add pricing issues to long-suffering Petrobras (PBR) shareholders’ pile of worries. Shares of PBR stock are falling hard today, currently down 10% at press time.
- [By Paul Ausick]
Big Earnings Movers: Petroleo Brasileiro SA (NYSE: PBR) is up 9.1% at $17.35 after reporting earnings and getting a ratings boost. Merck & Co. Inc. (NYSE: MRK) is down 2.5% at $45.39 as the company struggles to boost revenues. Burger King Worldwide Inc. (NYSE: BKW) is up 5.8% at $20.91 as franchise revenues rose much faster than costs. Loews Corp. (NYSE: L) is down 0.2% at $48.70.
- [By Bruce Kennedy]
The EIA examined annual reports from 42 oil and natural gas companies, from giants like Brazil's Petrobras (NYSE: PBR) and ExxonMobil (NYSE: XOM) to smaller firms like Talisman Energy (NYSE: TLM) and Encana (NYSE: ECA) ��companies that reportedly made up about 40 percent of non-OPEC production last year, and that had combined market capitalization of over $2.4 trillion.
- [By Stephan Dube]
Petrobras SA (NYSE: PBR ) �currently produces above 300,000 barrels of oil equivalent per day, 43% in the Santos basin and 57% in the Campos basin. Petrobras achieved this level of production with only 17 wells in pre-salt basins located in offshore Brazil. Furthermore, about 96% of its total production is achieved in Brazil, and the company currently has 69 floating rigs for well construction and maintenance in the country.
Petrobras holds world-class assets with tremendous potential that will boost its operating income in the coming years. From January 2012 to February 2013, a hefty 53 discoveries were made of which 25 were offshore, including 15 in pre-salt basins. According to the producer, production of more than one million barrels per day should be reached by 2017, and over 2.1 Mmbbls/d could be reached by 2020 for its pre-salt assets.
Best Supermarket Stocks To Buy For 2014: Fortune Brands Home & Security Inc (FBHS)
Fortune Brands Home & Security, Inc., incorporated on June 9, 1988, is engaged in home and security products with companies focused on the design, manufacture and sale of products in Kitchen & Bath Cabinetry, Plumbing & Accessories, advanced material windows & entry door Systems, and security and storage products. The Company operates through four business segments: Kitchen & Bath Cabinetry, Plumbing & Accessories, Advanced Material Windows & Door Systems, and Security & Storage. The Kitchen & Bath Cabinetry segment manufactures custom, semi-custom, and stock cabinetry for the kitchen, bath, and other areas of the home. Plumbing & Accessories segment manufactures and assembles faucets, accessories, and kitchen sinks. The Advanced Material Windows & Door Systems segment manufactures and sells fiberglass and steel entry door systems. The Security & Storage segment provides locks, safety, and security devices and electronic security products. In June 2013, Fortune Brands Home & Security Inc completed the acquisition of WoodCrafters Home Products.
Kitchen & Bath Cabinetry
The Company�� Kitchen & Bath Cabinetry segment�� products includes brand names, such as Aristokraft, Omega, Kitchen Craft, Schrock, Diamond, HomeCrest, Decora, Kemper, Thomasville and Martha Stewart Living. Principally all of this segment�� sales are in North America. The Company sells directly to kitchen and bath dealers, home centers, wholesalers and builders. During the year ended December 31, 2012, sales to The Home Depot and Lowe's consisted of approximately 32% of net sales of the Kitchen & Bath Cabinetry segment.
The Company competes with Masco and American Woodmark.
Plumbing & Accessories
The Plumbing & Accessories segment manufactures accessories and kitchen sinks in North America, China and India, predominantly under the Moen brand. The sells its Plumbing & Accessories products principally in the United States and Canada. It also sells them in China, India, ! Mexico, South America and Southeast Asia. It sells directly through its own sales force and indirectly through independent manufacturers��representatives, primarily to wholesalers, home centers, mass merchandisers and industrial distributors. During 2012, sales to The Home Depot and Lowe's consisted of approximately 29% of net sales of the Plumbing & Accessories segment.
The Company competes with Delta, Kohler, Pfister and American Standard.
Advanced Material Windows & Door Systems
The Company�� Advanced Material Windows & Door Systems segment manufactures fiberglass and steel entry door systems, vinyl-framed window and patio doors, and urethane millwork product lines. Therma-Tru products include fiberglass and steel residential entry door and patio door systems, primarily for sale in the United States and Canada. Simonton brand of vinyl-framed windows and patio doors are mainly manufactured and sold in the United States. The segment�� principal customers are home centers, millwork building products and wholesale distributors, and specialty dealers that provide products to the residential new construction market, as well as to the remodeling and renovation markets. During 2012, sales to The Home Depot and Lowe�� comprised approximately 17% of net sales of the Advanced Material Windows & Door Systems segment.
The Company competes with Masonite, JELD-WEN and Plastpro, Silverline, Atrium and Milgard.
Security & Storage
The Company�� Security & Storage segment consists of locks, safety and security devices, and electronic security products manufactured, sourced and distributed by Master Lock and tool storage and garage organization products manufactured by Waterloo. The segment sells products principally in the United States Canada, Europe, Australia and Central America. Master Lock manufactures and sells key-controlled and combination padlocks, bicycle and cable locks, built-in locker locks, door hardware, automotive, t! railer an! d towing locks, and other specialty safety and security devices. Master Lock sells products for consumer use to hardware and other retail outlets, wholesale distributors and home centers, industrial and institutional users, original equipment manufacturers and retail outlets. During 2012, Security & Storage sales to international markets comprised approximately 20% of sales.
Waterloo manufactures tool storage and garage organization products, steel toolboxes, tool chests, workbenches and related products. Waterloo primarily sells to Sears retail stores. In addition, Waterloo sells under the Waterloo and private-label brand names to specialty industrial and automotive dealers, mass merchandisers, home centers and hardware stores.
The Company competes with Asian importers, Homak, Stanley Black & Decker, Snap-On, Kennedy, Stack-On and others in the metal storage segment and with Stanley Black & Decker, Keter, Newell Rubbermaid
Advisors' Opinion:- [By Marc Bastow]
Home security products distributor Fortune Brands Home and Security (FBHS) raised its quarterly dividend 20% to 12 cents per share, payable on March 19 to shareholders of record as of Feb. 28.
FBHS Dividend Yield: 1.13% - [By Joseph Gacinga]
Another notable case is the spinoff of Fortune Brands Home & Security (NYSE: FBHS ) from Beam (NYSE: BEAM ) in 2011. Fortune Brands Home & Security shares have climbed at a much faster clip than Beam's shares since then.
- [By Travis Hoium]
What: Shares of Fortune Brands Home & Security (NYSE: FBHS ) jumped as much as 11% in early trading after the company released earnings.
- [By John Udovich]
After the bedroom, the kitchen is probably the place where we spend the most time awake in our homes with small cap kitchen stocks Caesarstone Sdot-Yam Ltd (NASDAQ: CSTE) and American Woodmark Corporation (NASDAQ: AMWD) along with diversified midcap Fortune Brands Home & Security Inc (NYSE: FBHS) all putting in a good performance. After all, any sort of housing recovery with more new homes being sold will�help kitchen stocks and so will increased sales of older or foreclosed homes that need to have their kitchens remodeled. But which is the better kitchen stock for investors? Here is�closer look at all three:
Best Supermarket Stocks To Buy For 2014: Manulife Financial Corp (MFC)
Manulife Financial Corporation (MFC) is a Canada-based financial services group with principal operations in Asia, Canada and the United States. The Company�� segments are Asia, Canadian and U.S. Divisions and the Corporate and Other segment. The Company�� international network agents and distribution partners offers financial protection and wealth management products and services to clients. It also provides asset management services to institutional customers. In January 2013, the Company acquired Benesure Canada Inc. In August 2013, John Hancock, the United States division of the Company, announced that it has acquired Landmark Square in Long Beach, California. In December 2013, MFC announced its subsidiary, Manulife (International) Limited, had completed the transaction to sell its life insurance business in Taiwan to CTBC Life Insurance Co., Ltd. Advisors' Opinion:- [By Jonas Elmerraji]
Manulife Financial (MFC) is another stock that's forming an ascending triangle pattern right now. In the case of this $33 billion Canadian financial services firm, resistance comes into play at $18, a price level that's acted as a ceiling for shares since all the way back in July. The buy signal comes on a move through that $18 barrier.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Triangles, and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That $18 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
After it happens, I'd recommend keeping a protective stop at $16.50.
- [By Eric Lam]
Air Canada, the nation�� largest airline, surged 7.2 percent after reducing costs. Manulife Financial Corp. (MFC), Canada�� largest insurer, increased 2.6 percent for a fourth day of gains. Trilogy Energy Corp. plunged 9.8 percent after reporting a loss as sales declined. Detour Gold Corp. plunged 18 percent after saying it will not meet its 2013 production targets. Centerra Gold Inc. and HudBay Minerals Inc. sank at least 3.7 percent as gold dropped to a three-week low in New York.
Best Supermarket Stocks To Buy For 2014: ABS-CBN Corp (ABS)
ABS-CBN Corporation is primarily involved in television and radio broadcasting, as well as in the production of television and radio programming for domestic and international audiences and other related businesses. The Company operates through three business segments. Broadcasting segment is principally involved in the television and radio broadcasting activities, which generates revenue from sale of national and regional advertising time. Cable and satellite business primarily develops and produces programs for cable television, including delivery of television programming outside the Philippines through its direct-to-home (DTH) satellite service, cable television channels and blocked time on television stations. Other businesses include movie production, consumer products and services. The Company�� subsidiaries include ABS-CBN Publishing, Inc., Star Recording, Inc., Roadrunner Network, Inc., Star Songs, Inc., Sarimanok News Network, Inc. and ABS-CBN Interactive, Inc. Advisors' Opinion:- [By John Emerson]
During the housing bubble, lending standards were becoming relaxed and the practice of bundling subprime loans into collateralized debt obligations (CDOs) became a mainstream practice. These securities were backed by highly inflated credit ratings even though the quality of the underlying assets was highly questionable. By 2007, the worldwide demand for this type of asset-backed security (ABS) was beginning to wane and the mortgages which provided the collateral for the securities were starting to come into question.
No comments:
Post a Comment